OLIVE LABORATORIES products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Rawat · Pakistan
Rawat-based pharmaceutical manufacturer established in 2003 with tablet, syrup and capsule manufacturing sections.
OLIVE LABORATORIES products in Pakistan
OLIVE LABORATORIES has 28 medicine presentations registered in Pakistan under 16 brands, covering 15 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Cardiovascular. Its brands with the most registered strengths and packs are Meprolive (Omeprazole), Azolive (Azithromycin), Rebveen (Ribavirin) and Algicare (Loratadine). 28 products have an official DRAP price on MedInfoBase. See all 16 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- 52, S-6, National Industrial Zone, Rawat, Rawalpindi, Pakistan
- Website
- olivelaboratories.com ↗
- Phone
- +92 51 4499213; +92 51 4499193; +92 51 4499621
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where OLIVE LABORATORIES is priced against the market
27 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Algicare | Loratadine | 10 mg | Tablet | 10's | 031627 | PKR 82.14 | PKR 8.21/tablet | 🔒 Pharma Pro |
| Algicare | Loratadine | 5 mg/5 mL | Syrup | 60 ml | 031628 | PKR 93.87 | PKR 1.56/mL | 🔒 Pharma Pro |
| Azolive | Azithromycin | 250 mg | Tablet | 10's | 038233 | PKR 485.47 | PKR 48.55/tablet | 🔒 Pharma Pro |
| Azolive | Azithromycin | 250 mg | Tablet | 06's | 038233 | PKR 300.99 | PKR 50.17/tablet | 🔒 Pharma Pro |
| Azolive | Azithromycin | 500 mg | Film-coated tablet | 06's | 106161 | PKR 393.26 | PKR 65.54/tablet | 🔒 Pharma Pro |
| Cardive | Losartan | 50 mg | Tablet | 20's | 031643 | PKR 407.79 | PKR 20.39/tablet | 🔒 Pharma Pro |
| Ciprolive | Ciprofloxacin | 250 mg | Tablet | 10's | 038234 | PKR 249.00 | PKR 24.90/tablet | 🔒 Pharma Pro |
| Ciprolive | Ciprofloxacin | 500 mg | Tablet | 10's | 038235 | PKR 498.01 | PKR 49.80/tablet | 🔒 Pharma Pro |
| Dinolive | Ranitidine | 150 mg | Tablet | 10's | 056256 | PKR 107.27 | PKR 10.73/tablet | 🔒 Pharma Pro |
| E-Thro | Azithromycin | 250 mg | Capsule | 6's | 056243 | PKR 297.10 | PKR 49.52/capsule | 🔒 Pharma Pro |
| E-Thro | Azithromycin | 250 mg | Capsule | 10's | 056243 | PKR 495.18 | PKR 49.52/capsule | 🔒 Pharma Pro |
| G - Flax | Fluoxetine | 20 mg | Tablet | 10's | 042782 | PKR 124.50 | PKR 12.45/tablet | 🔒 Pharma Pro |
| G-xone 1.0g I.V InjectionRegistry verified | Ceftriaxone (as Sodium) | — | — | — | 045231Official source ↗ | No indexed price | — | — |
| G-xone 250mg Injection I.MRegistry verified | Ceftriaxone (as Sodium) | — | — | — | 045230Official source ↗ | No indexed price | — | — |
| G-xone 500mg InjectionRegistry verified | Ceftriaxone (as Sodium) | — | — | — | 045229Official source ↗ | No indexed price | — | — |
| Kencil | Linezolid | 600 mg | Tablet | 12's | 095319 | PKR 4,728.41 | PKR 394.03/tablet | 🔒 Pharma Pro |
| Loxelive | Moxifloxacin | 400 mg | Tablet | 5's | 095316 | PKR 878.71 | PKR 175.74/tablet | 🔒 Pharma Pro |
| Malarial | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 16's | 056259 | PKR 612.93 | PKR 38.31/tablet | 🔒 Pharma Pro |
| Meprolive | Omeprazole | 20 mg | Capsule | 14s | 056245 | PKR 275.83 | PKR 19.70/capsule | 🔒 Pharma Pro |
| Meprolive | Omeprazole | 20 mg | Capsule | 10s | 056245 | PKR 197.29 | PKR 19.73/capsule | 🔒 Pharma Pro |
| Meprolive | Omeprazole | 40 mg | Capsule | 14's | 056246 | PKR 478.85 | PKR 34.20/capsule | 🔒 Pharma Pro |
| Meprolive | Omeprazole | 40 mg | Capsule | 10's | 056246 | PKR 342.87 | PKR 34.29/capsule | 🔒 Pharma Pro |
| Nestaten | Nystatin | 500000 IU/5 mL | Oral drops | 15 ml | 066230 | PKR 24.90 | PKR 1.66/mL | No comparator |
| Ovilox | Levofloxacin | 250 mg | Tablet | 10's | 038229 | PKR 478.85 | PKR 47.89/tablet | 🔒 Pharma Pro |
| Ovilox | Levofloxacin | 500 mg | Tablet | 10's | 038230 | PKR 796.82 | PKR 79.68/tablet | 🔒 Pharma Pro |
| Rebveen | Ribavirin | 400 mg | Capsule | 30's | 072844 | PKR 475.03 | PKR 15.83/capsule | 🔒 Pharma Pro |
| Rebveen | Ribavirin | 400 mg | Capsule | 10's | 072844 | PKR 172.39 | PKR 17.24/capsule | 🔒 Pharma Pro |
| Rebveen | Ribavirin | 400 mg | Capsule | 20's | 072844 | PKR 327.54 | PKR 16.38/capsule | 🔒 Pharma Pro |
| Setamol | Paracetamol | 500 mg | Tablet | 200's | 095430 | PKR 727.01 | PKR 3.64/tablet | 🔒 Pharma Pro |
| Simolive | Simvastatin | 10 mg | Tablet | 10 S | 031638 | PKR 325.62 | PKR 32.56/tablet | 🔒 Pharma Pro |
| Simolive | Simvastatin | 20 mg | Tablet | 10 S | 031639 | PKR 526.74 | PKR 52.67/tablet | 🔒 Pharma Pro |
| Trivolive 250mg InjectionRegistry verified | Ceftriaxone (as sodium) | — | — | — | 045230DOfficial source ↗ | No indexed price | — | — |
| Trivolive 500mg InjectionRegistry verified | Ceftriaxone (as sodium) | — | — | — | 045229DOfficial source ↗ | No indexed price | — | — |
All 16 OLIVE LABORATORIES brands in Pakistan
- Algicare Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Azolive Azithromycin · 250 mg tablet, 500 mg tablet
- Cardive Losartan · 50 mg tablet
- Ciprolive Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Dinolive Ranitidine · 150 mg tablet
- E-Thro Azithromycin · 250 mg capsule
- G - Flax Fluoxetine · 20 mg tablet
- Kencil Linezolid · 600 mg tablet
- Loxelive Moxifloxacin · 400 mg tablet
- Malarial Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Meprolive Omeprazole · 20 mg capsule, 40 mg capsule
- Nestaten Nystatin · 500000 IU/5 mL drops
- Ovilox Levofloxacin · 250 mg tablet, 500 mg tablet
- Rebveen Ribavirin · 400 mg capsule
- Setamol Paracetamol · 500 mg tablet
- Simolive Simvastatin · 10 mg tablet, 20 mg tablet
OLIVE LABORATORIES: common questions
How many products does OLIVE LABORATORIES have in Pakistan?
OLIVE LABORATORIES has 28 registered medicine presentations in Pakistan, sold under 16 brands and covering 15 generic medicines.
What are the main brands of OLIVE LABORATORIES?
By number of registered strengths and packs, its largest brands are Meprolive (Omeprazole), Azolive (Azithromycin), Rebveen (Ribavirin), Algicare (Loratadine) and Ciprolive (Ciprofloxacin). This is not a sales ranking.
Which therapy areas does OLIVE LABORATORIES cover?
The most products are in Anti-infectives (16), Gastrointestinal & hepatology (5), Cardiovascular (3), Respiratory & allergy (2) and CNS & mental health (1).
Where can I see OLIVE LABORATORIES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.